标题
Therapeutic approaches to Epstein–Barr virus cancers
作者
关键词
-
出版物
Current Opinion in Virology
Volume 56, Issue -, Pages 101260
出版商
Elsevier BV
发表日期
2022-09-27
DOI
10.1016/j.coviro.2022.101260
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin’s Lymphoma
- (2022) Shazia Nakhoda et al. Cancers
- Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma
- (2021) David Johnson et al. ORAL ONCOLOGY
- EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer
- (2021) Samantha S. Soldan et al. Gastric Cancer
- Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma
- (2021) Saidu Kamara et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Landscape of EBV-positive gastric cancer
- (2021) Motonobu Saito et al. Gastric Cancer
- Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1
- (2021) Julius Maximilian Knerr et al. Cancers
- Estimating the global burden of Epstein–Barr virus-related cancers
- (2021) Yide Wong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer
- (2020) Jin Zhao et al. CANCER LETTERS
- Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA
- (2020) Troy E. Messick et al. MOLECULES
- Tenofovir prodrugs potently inhibit Epstein–Barr virus lytic DNA replication by targeting the viral DNA polymerase
- (2020) Natalia C. Drosu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
- (2020) Constanze Slabik et al. Molecular Therapy-Oncolytics
- The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
- (2020) Angela Kwok-Fung Lo et al. Cancers
- Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
- (2020) Stephanie Pei Tung Yiu et al. Cancers
- The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review
- (2020) Klemens Ruprecht Expert Review of Clinical Immunology
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
- (2019) Rashmi R. Shah DRUG SAFETY
- Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
- (2019) Suzan Fares et al. mBio
- Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
- (2019) Troy E. Messick et al. Science Translational Medicine
- Novel Therapeutics for Epstein–Barr Virus
- (2019) Graciela Andrei et al. MOLECULES
- CAR T cells generated using Sleeping Beauty transposon vectors and expanded with an EBV-transformed lymphoblastoid cell line (LCL) display antitumor activity in vitro and in vivo
- (2019) Leonardo Chicaybam et al. HUMAN GENE THERAPY
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- Development of a novel inducer for EBV lytic therapy
- (2019) Nadezhda Tikhmyanova et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
- (2019) Yasuo Takashima et al. Scientific Reports
- Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
- (2019) Krzysztof Wojtak et al. Vaccines
- Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
- (2019) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- The Global Landscape of EBV-Associated Tumors
- (2019) Claire Shannon-Lowe et al. Frontiers in Oncology
- Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma
- (2019) Stephanie Pei Tung Yiu et al. Cancers
- Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1
- (2019) Sage L. Atkins et al. ANTIVIRAL RESEARCH
- Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra
- (2018) Dimitri Topalis et al. DRUG RESISTANCE UPDATES
- Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma
- (2018) Denis Terziev et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein–Barr virus status, and cancer genome alterations in metastatic gastric cancer
- (2018) Akihito Kawazoe et al. Gastric Cancer
- Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
- (2018) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein–Barr Virus and Cancer
- (2018) Paul J. Farrell Annual Review of Pathology-Mechanisms of Disease
- EBV/LMP-specific T cells maintain remissions of T and B cell EBV lymphomas after allogeneic bone marrow transplantation
- (2018) Lauren P. McLaughlin et al. BLOOD
- CD40L-adjuvanted DNA vaccine carrying EBV-LMP2 antigen enhances anti-tumor effect in NPC transplantation tumor animal
- (2018) Lei Lei et al. Central European Journal of Immunology
- Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
- (2018) Dwain G. van Zyl et al. PLoS Pathogens
- Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
- (2018) Adam Z. Cheng et al. Nature Microbiology
- Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers
- (2018) Stephanie Yiu et al. Cancers
- Varicella and herpes zoster vaccine development: lessons learned
- (2017) Charlotte Warren-Gash et al. Expert Review of Vaccines
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma
- (2017) Marc L. Ooft et al. ORAL ONCOLOGY
- Herpes zoster vaccine live: A 10 year review of post-marketing safety experience
- (2017) English D. Willis et al. VACCINE
- Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation
- (2017) Nadezhda Tikhmyanova et al. PLoS Pathogens
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
- (2016) Andy J. Minn et al. CELL
- Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure
- (2016) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design
- (2016) Eleonora Gianti et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
- (2016) Aaron Goodman et al. Nature Reviews Clinical Oncology
- Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
- (2016) Xinle Cui et al. VACCINE
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
- (2015) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma
- (2015) Sharon D. Stoker et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells
- (2014) Lijun Jiang et al. CHEMICAL COMMUNICATIONS
- Modes of infection and oncogenesis by the Epstein-Barr virus
- (2014) Takayuki Murata et al. REVIEWS IN MEDICAL VIROLOGY
- Identification of a New Class of Small Molecules That Efficiently Reactivate Latent Epstein–Barr Virus
- (2013) Nadezhda Tikhmyanova et al. ACS Chemical Biology
- EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail
- (2013) B. D. Griffin et al. JOURNAL OF IMMUNOLOGY
- Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
- (2013) Whay-Kuang Chia et al. MOLECULAR THERAPY
- Switching of EBV cycles between latent and lytic states
- (2013) Takayuki Murata et al. REVIEWS IN MEDICAL VIROLOGY
- Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization
- (2012) Sun Young Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
- (2012) C. Smith et al. CANCER RESEARCH
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral Production
- (2010) Q. Meng et al. JOURNAL OF VIROLOGY
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Histone Hyperacetylation Occurs on Promoters of Lytic Cycle Regulatory Genes in Epstein-Barr Virus-Infected Cell Lines Which Are Refractory to Disruption of Latency by Histone Deacetylase Inhibitors
- (2008) J. K. Countryman et al. JOURNAL OF VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started